USD10
ABEO Shares
About Abeona TherapeuticsAbeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
USD10
ABEO Shares
About Abeona TherapeuticsAbeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$398.97M
OPEN PRICE
$6.90
LOW (1Y)
$4.00
HIGH (1Y)
$7.54
LOW (24H)
$6.87
HIGH (24H)
$7.17
VOLUME (24H)
$777.46K
29.97%
Price history
Time | Price | Change |
|---|---|---|
Today | $6.90 | |
1 Day | $6.96 | |
1 Week | $7.01 | |
1 Month | $5.74 | |
1 Year | $6.75 |
Past performance is not a reliable indicator of future results.
Discover more
Popular cryptocurrencies
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.